N-acetylmannosamine

DB12536InvestigationalSmall molecule

N-acetylmannosamine is under investigation for the other of GNE Myopathy.

Mechanism: Pharmacologically active on N-acetyl-D-glucosamine kinase and Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase
Curator reviewed
Formula / weight: C₈H₁₅NO₆ · 221.2078 g/mol (avg)
Also known as: MANNAC

Resolves to

Compound

Structure

InChIKeyMBLBDJOUHNCFQT-WCTZXXKLSA-NSMILES[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(NC(C)=O)C=O

Targets

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with N-acetylmannosamine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.